Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), . Treffer: 20

2020

Craciun, A; Lackner, C; Cortez-Pinto, H Nonalcoholic Fatty Liver Disease versus Alcohol-related Liver Disease: Is it Really so Different?
CURR PHARM DESIGN. 2020; 26(10): 1093-1109.
Web of Science PubMed FullText FullText_MUG

 

Mörwald, K; Aigner, E; Bergsten, P; Brunner, SM; Forslund, A; Kullberg, J; Ahlström, H; Manell, H; Roomp, K; Schütz, S; Zsoldos, F; Renner, W; Furthner, D; Maruszczak, K; Zandanell, S; Weghuber, D; Mangge, H Serum Ferritin Correlates With Liver Fat in Male Adolescents With Obesity.
Front Endocrinol (Lausanne). 2020; 11: 340-340. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Safari, Z; Bruneau, A; Monnoye, M; Mariadassou, M; Philippe, C; Zatloukal, K; Gerard, P Murine Genetic Background Overcomes Gut Microbiota Changes to Explain Metabolic Response to High-Fat Diet
NUTRIENTS. 2020; 12(2): 287 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2019

Kaltenecker, D; Themanns, M; Mueller, KM; Spirk, K; Suske, T; Merkel, O; Kenner, L; Luís, A; Kozlov, A; Haybaeck, J; Müller, M; Han, X; Moriggl, R Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression.
Cytokine. 2018; 154569-154569 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Denkmayr, L; Feldman, A; Stechemesser, L; Eder, SK; Zandanell, S; Schranz, M; Strasser, M; Huber-Schönauer, U; Buch, S; Hampe, J; Paulweber, B; Lackner, C; Haufe, H; Sotlar, K; Datz, C; Aigner, E Lean Patients with Non-Alcoholic Fatty Liver Disease Have a Severe Histological Phenotype Similar to Obese Patients.
J Clin Med. 2018; 7(12): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Schweiger, M; Romauch, M; Schreiber, R; Grabner, GF; Hütter, S; Kotzbeck, P; Benedikt, P; Eichmann, TO; Yamada, S; Knittelfelder, O; Diwoky, C; Doler, C; Mayer, N; De Cecco, W; Breinbauer, R; Zimmermann, R; Zechner, R Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice.
Nat Commun. 2017; 8(5):14859-14859 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Munteanu, M; Tiniakos, D; Anstee, Q; Charlotte, F; Marchesini, G; Bugianesi, E; Trauner, M; Romero Gomez, M; Oliveira, C; Day, C; Dufour, JF; Bellentani, S; Ngo, Y; Traussnig, S; Perazzo, H; Deckmyn, O; Bedossa, P; Ratziu, V; Poynard, T; FLIP Consortium and the FibroFrance Group Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference.
Aliment Pharmacol Ther. 2016; 44(8):877-889 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Beilfuss, A; Sowa, JP; Sydor, S; Beste, M; Bechmann, LP; Schlattjan, M; Syn, WK; Wedemeyer, I; Mathé, Z; Jochum, C; Gerken, G; Gieseler, RK; Canbay, A Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently.
Gut. 2015; 64(5):791-799
Web of Science PubMed FullText FullText_MUG

 

Mangge, H; Baumgartner, BG; Zelzer, S; Prüller, F; Schnedl, WJ; Reininghaus, EZ; Haybaeck, J; Lackner, C; Stauber, R; Aigner, E; Weghuber, D Patatin-like phospholipase 3 (rs738409) gene polymorphism is associated with increased liver enzymes in obese adolescents and metabolic syndrome in all ages.
Aliment Pharmacol Ther. 2015; 42(1):99-105 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mueller, M; Thorell, A; Claudel, T; Jha, P; Koefeler, H; Lackner, C; Hoesel, B; Fauler, G; Stojakovic, T; Einarsson, C; Marschall, HU; Trauner, M Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity.
J Hepatol. 2015; 62(6):1398-1404 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Stättermayer, AF; Traussnigg, S; Dienes, HP; Aigner, E; Stauber, R; Lackner, K; Hofer, H; Stift, J; Wrba, F; Stadlmayr, A; Datz, C; Strasser, M; Maieron, A; Trauner, M; Ferenci, P Hepatic steatosis in Wilson disease--Role of copper and PNPLA3 mutations.
J Hepatol. 2015; 63(1):156-163
Web of Science PubMed FullText FullText_MUG

 

Wruck, W; Kashofer, K; Rehman, S; Daskalaki, A; Berg, D; Gralka, E; Jozefczuk, J; Drews, K; Pandey, V; Regenbrecht, C; Wierling, C; Turano, P; Korf, U; Zatloukal, K; Lehrach, H; Westerhoff, HV; Adjaye, J Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes.
Sci Data. 2015; 2(S 01):150068-150068 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

2014

Bettermann, K; Hohensee, T; Haybaeck, J Steatosis and steatohepatitis: complex disorders.
Int J Mol Sci. 2014; 15(6):9924-9944 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fuchs, CD; Claudel, T; Trauner, M Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD.
Trends Endocrinol Metab. 2014; 25(11):576-585
Web of Science PubMed FullText FullText_MUG

 

Kessler, SM; Simon, Y; Gemperlein, K; Gianmoena, K; Cadenas, C; Zimmer, V; Pokorny, J; Barghash, A; Helms, V; van Rooijen, N; Bohle, RM; Lammert, F; Hengstler, JG; Mueller, R; Haybaeck, J; Kiemer, AK Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.
Int J Mol Sci. 2014; 15(4):5762-5773 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pandey, V; Sultan, M; Kashofer, K; Ralser, M; Amstislavskiy, V; Starmann, J; Osprian, I; Grimm, C; Hache, H; Yaspo, ML; Sültmann, H; Trauner, M; Denk, H; Zatloukal, K; Lehrach, H; Wierling, C Comparative analysis and modeling of the severity of steatohepatitis in DDC-treated mouse strains.
PLoS One. 2014; 9(10):e111006-e111006 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Wree, A; Schlattjan, M; Bechmann, LP; Claudel, T; Sowa, JP; Stojakovic, T; Scharnagl, H; Köfeler, H; Baba, HA; Gerken, G; Feldstein, AE; Trauner, M; Canbay, A Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients.
Metabolism. 2014; 63(12):1542-1552
Web of Science PubMed FullText FullText_MUG

 

2012

Bechmann, LP; Hannivoort, RA; Gerken, G; Hotamisligil, GS; Trauner, M; Canbay, A The interaction of hepatic lipid and glucose metabolism in liver diseases.
J Hepatol. 2012; 56(4):952-964 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Heuer, M; Kaiser, GM; Kahraman, A; Banysch, M; Saner, FH; Mathé, Z; Gerken, G; Paul, A; Canbay, A; Treckmann, JW Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience.
Digestion. 2012; 86(2):107-113
Web of Science PubMed FullText FullText_MUG

 

2010

Trauner, M; Claudel, T; Fickert, P; Moustafa, T; Wagner, M Bile acids as regulators of hepatic lipid and glucose metabolism.
Dig Dis. 2010; 28(1):220-224
Web of Science PubMed FullText FullText_MUG Google Scholar

 

© Med Uni Graz Impressum